| 1 |
Yang X, Smith JL, Beck MT, Wilkinson JM, Michaud A, Vasta JD, Robers MB, Willson TM. Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live Cells. bioRxiv 2023:2023. [PMID: 36865333 DOI: 10.1101/2023.02.25.529946] [Reference Citation Analysis]
|
| 2 |
Al-maliki L, Oohayyed NA, Mohameed EE, Suleiman AA, Shaban SA. Identification of Novel Drug Targets and Immune Response Biomarkers in HCMV-Infected Hosts.. [DOI: 10.21203/rs.3.rs-2608712/v1] [Reference Citation Analysis]
|
| 3 |
Hajjo R, Sabbah DA, Abusara OH, Kharmah R, Bardaweel S. Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. Viruses 2023;15. [PMID: 36851782 DOI: 10.3390/v15020568] [Reference Citation Analysis]
|
| 4 |
Ogorek TJ, Golden JE. Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses. Viruses 2023;15. [PMID: 36851628 DOI: 10.3390/v15020413] [Reference Citation Analysis]
|
| 5 |
Minadakis G, Tomazou M, Dietis N, Spyrou GM. Vir2Drug: a drug repurposing framework based on protein similarities between pathogens. Brief Bioinform 2023;24. [PMID: 36513376 DOI: 10.1093/bib/bbac536] [Reference Citation Analysis]
|
| 6 |
Beaven E, Kumar R, Bhatt HN, Esquivel SV, Nurunnabi M. Myofibroblast specific targeting approaches to improve fibrosis treatment. Chem Commun (Camb) 2022;58:13556-71. [PMID: 36445310 DOI: 10.1039/d2cc04825f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Qayed WS, Ferreira RS, Silva JRA. In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations. Molecules 2022;27:5988. [DOI: 10.3390/molecules27185988] [Reference Citation Analysis]
|
| 8 |
García-marín J, Rodríguez-puyol D, Vaquero JJ. Insight into the mechanism of molecular recognition between human Integrin-Linked Kinase and Cpd22 and its implication at atomic level. J Comput Aided Mol Des. [DOI: 10.1007/s10822-022-00466-1] [Reference Citation Analysis]
|
| 9 |
Yang X, Dickmander RJ, Bayati A, Taft-Benz SA, Smith JL, Wells CI, Madden EA, Brown JW, Lenarcic EM, Yount BL Jr, Chang E, Axtman AD, Baric RS, Heise MT, McPherson PS, Moorman NJ, Willson TM. Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses. ACS Chem Biol 2022. [PMID: 35723434 DOI: 10.1021/acschembio.2c00378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Chandrasekaran B, Saravanan M. Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I. Front Pharmacol 2022;13:916324. [DOI: 10.3389/fphar.2022.916324] [Reference Citation Analysis]
|
| 11 |
Xie Z, Hou S, Yang X, Duan Y, Han J, Wang Q, Liao C. Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts. J Med Chem 2022. [PMID: 35235745 DOI: 10.1021/acs.jmedchem.1c02190] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 12 |
Wild M, Hahn F, Brückner N, Schütz M, Wangen C, Wagner S, Sommerer M, Strobl S, Marschall M. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations. Int J Mol Sci 2022;23:2493. [PMID: 35269635 DOI: 10.3390/ijms23052493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Yang X, Dickmander RJ, Bayati A, Taft-Benz SA, Smith JL, Wells CI, Madden EA, Brown JW, Lenarcic EM, Yount BL Jr, Chang E, Axtman AD, Baric RS, Heise MT, McPherson PS, Moorman NJ, Willson TM. Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2. bioRxiv 2022:2022. [PMID: 35018375 DOI: 10.1101/2022.01.03.474779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Ye H, Sun M, Huang S, Xu F, Wang J, Liu H, Zhang L, Luo W, Guo W, Wu Z, Zhu J, Li H. Gene Network Analysis of Hepatocellular Carcinoma Identifies Modules Associated with Disease Progression, Survival, and Chemo Drug Resistance. Int J Gen Med 2021;14:9333-47. [PMID: 34898998 DOI: 10.2147/IJGM.S336729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Demuro S, Di Martino RMC, Ortega JA, Cavalli A. GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways. Int J Mol Sci 2021;22:9098. [PMID: 34445804 DOI: 10.3390/ijms22169098] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
